NSAID

Inhibition of miosis during cataract surgery. Postoperative inflammation after cataract surgery and other surgical procedures. Preoperative and postoperative prevention of cystoid macular oedema associated with lens extraction and intraocular lens implantation. Non-infectious inflammatory conditions affecting the anterior region of the eye (e.g. chronic non-infectious conjunctivitis). Post-traumatic inflammation in penetrating and non- penetrating wounds (as an adjuvant to local anti-infective therapy).

Diclofenac Sodium B.P 0.1 % w/v

Each LDPE dropper bottle contains 5 ml drops

Adults: Preoperative : 1 drop up to 5 times over the 3 hours preceding surgery. Postoperative : 1 drop 3 times immediately after surgery, thereafter 1 drop 3-5 times daily for as long as required. Other indications: 1 drop 4-5 times daily, depending on the severity of the condition. Long- term treatment should be considered only after careful assessment of the indication and ophthalmological examination. Children: No specific investigations have been carried out on the use of Diclofenac Eye Drops in children.

Known hypersensitivity to diclofenac or thiomersal. Like other non-steroidal anti-inflammatory agents, Erdon is contraindicated in patients in whom attacks of asthma, urticaria or acute rhinitis have been observed following application of acetyl salicylic acid or other cyclo-oxygenase inhibitors.

Occasional: Nausea, vomiting. Rare: Systemic hypersensitivity reactions like asthma, urticaria, itching, acute rhinitis. The following unwanted effects have been observed during clinical studies with Diclofenac Eye Drops. Occasional mild or moderate, transient stinging and/or blurred vision directly after application of eye drops.

Erdon can be combined with eye drops containing steroids, if necessary. To prevent the active substance being washed out by further doses, an interval of at least 5 minutes should be allowed to elapse between each application.

Aristopharma Ltd., Bangladesh.